Fleury’s R$136,8 Million Acquisition of Vita

Veirano Advogados advised Fleury, while HB Advogados advised GVORTO on the deal.

Fleury S.A., through its wholly-owned subsidiary Fleury Centro de Procedimentos Médicos Avançados S.A., executed the acquisition of 66,7% of equity stake in Vita Ortopedia Serviços Médicos Especializados Ltda. and Vita Clínicas Medicina Especializada Ltda, from GVORTO Gestão e Participações Ltda. The enterprise value is approximately R$136,800,000.00.

The transaction also comprises an investment to be made by Fleury for the expansion of orthopedics services in Brazil.

BR Advice acted as financial advised to GVORTO.

Veirano Advogados advised Fleury with a team led by partner Vitor Rozenthal (Picture) and associate Maria Leticia Curtolo de Goes.

HB Advogados advised GVORTO with a team led by partner Daniel Barros, which included associates Leticia Flaminio Oliveira, Nicholas Tavares de Almeida Silveira, Filipe da Trindade Duarte.

Involved fees earner: Daniel Barros – Halembeck Barros Advogados; Filipe da Trindade Duarte – Halembeck Barros Advogados; Leticia Flaminio Oliveira – Halembeck Barros Advogados; Nicholas Tavares de Almeida Silveira – Halembeck Barros Advogados; Maria Letícia Curtolo de Goes – Veirano Advogados; Vitor Rozenthal – Veirano Advogados;

Law Firms: Halembeck Barros Advogados; Veirano Advogados;

Clients: Fleury Centro de Procedimentos Médicos Avançados SA; GVORTO Gestão e Participações Ltda;

Print Friendly, PDF & Email

Leave a Reply